Chloe Ramirez
Rabies vaccines have a long and distinguished history, with the first human rabies vaccination occurring in 1885. Since then, rabies vaccines have gone through several iterations, with newer and less expensive options now available. Despite these advancements, rabies remains a significant public health concern worldwide, with thousands of human deaths annually. This article will explore the history of rabies vaccine development, the current landscape of rabies prevention, and the ongoing challenges in ensuring widespread accessibility and coverage.
Explore related products
What You'll Learn
The first rabies vaccine was invented in 1885
On 6 July 1885, Pasteur performed the first human vaccination. The patient was nine-year-old Joseph Meister, who had been bitten 14 times by a rabid dog. Knowing that the boy would die without treatment, Pasteur, together with Dr Vulpian and Dr Jacques Joseph Grancher, injected him with material from a rabid rabbit spinal cord that had been dehydrated for 15 days. Over the next ten days, Meister received 12 additional doses of the vaccine, which had been air-dried for increasingly shorter periods, containing more virulent forms of the virus. The treatment was a success, and Meister survived.
The vaccine was reported to the French Academy of Sciences on 26 October 1885. Pasteur's methodology spread widely, and patients with rabies travelled from all over the world to receive the vaccine. In 1888, Dr Grancher set up the Institut Pasteur, dedicated to improving human health.
Religious Exemptions: Why Some Refuse Vaccines
You may want to see also
Explore related products
The vaccine was developed by Louis Pasteur
The first rabies vaccine was introduced in 1885 by Louis Pasteur, a French scientist. Before this breakthrough, rabies was a fatal disease with no cure, resulting in death in almost all cases.
Pasteur's vaccine was first used to treat nine-year-old Joseph Meister, who had been bitten multiple times by a rabid dog. Dr Jacques Joseph Grancher, who convinced Pasteur to use the vaccine on the boy, administered 12 doses of the vaccine over ten days. Meister survived, becoming the first human to be successfully vaccinated against rabies.
The vaccine was developed using nerve tissue from rabbits. The first injection was derived from the spinal cord of a rabbit that had died of rabies, and subsequent injections were made from infections of spinal cord tissue that had been desiccated for shorter periods, containing progressively more virulent forms of the virus. This approach, known as attenuation, was highly effective in protecting against rabies.
Pasteur's achievement in developing the rabies vaccine was significant, and his methodology spread widely. The vaccine's creation also led to the establishment of the Institut Pasteur, dedicated to improving human health. The institute was inaugurated in 1888, and Dr Grancher, who played a key role in its creation, was honoured for his contributions.
Today, rabies vaccines remain essential, with millions of people receiving them annually. The World Health Organization recommends vaccination for those at high risk, including children in endemic areas and individuals working with animals or the virus. Vaccination of domestic animals is also crucial in preventing transmission to humans.
Immunity: Diseases That Don't Confer Protection
You may want to see also
Explore related products
The first human to receive the vaccine was Joseph Meister
Rabies is a deadly zoonotic disease with a near 100% fatality rate once clinical symptoms manifest. The development of the rabies vaccine can be traced back to 1885, when French scientists Louis Pasteur and Émile Roux created the first vaccination. Before this breakthrough, rabies was a fatal disease with no cure.
On July 6, 1885, Meister received the first of 12 doses of the vaccine, which were administered over 10 days. The first injection was derived from the spinal cord of an inoculated rabbit that had died of rabies 15 days earlier. All the doses were obtained by attenuation, with later ones being progressively more virulent.
Remarkably, Joseph Meister survived, becoming the first person to be vaccinated against rabies. This success had far-reaching implications, with patients with rabies travelling from all over the world to receive the vaccine. The demand was so high that Dr. Grancher established a dedicated vaccination centre near Pasteur's laboratory, and he played a key role in the founding of the Institut Pasteur.
Today, rabies vaccines are safe for all age groups, and about 29 million people worldwide receive the vaccination annually. The World Health Organization recommends vaccinating those at high risk, such as children living in areas where rabies is common, as well as veterinarians and researchers.
Free Vaccines: What Employers Must Offer to Staff
You may want to see also
Explore related products
The vaccine was first tested on animals
The first rabies vaccine was introduced in 1885 by French scientist Louis Pasteur and his collaborator Émile Roux. Before this breakthrough, rabies was a fatal disease with a near 100% fatality rate. The vaccine was first tested on animals, specifically dogs and rabbits, before being administered to a human.
The vaccine's development was prompted by a nine-year-old boy named Joseph Meister, who, in 1885, was bitten 14 times by a rabid dog. Joseph's mother, Marie-Angélique, had heard of Pasteur's work and sought his help. Initially, Pasteur's collaborators were hesitant to administer the vaccine to Joseph, as it had only been tested on animals. However, Dr. Jacques Joseph Grancher convinced them otherwise, and the vaccine was successfully given to Joseph, saving his life.
Dr. Grancher played a crucial role in the development and administration of the rabies vaccine. He not only persuaded Pasteur to use the vaccine on Joseph but also actively participated in Pasteur's rabies research, including testing the vaccine on animals. Following Joseph's successful treatment, Dr. Grancher set up a dedicated vaccination centre near Pasteur's laboratory to accommodate the influx of patients seeking the vaccine.
The first rabies vaccine laid the foundation for subsequent advancements. In 1908, an improved version of the original vaccine was introduced. Over time, newer and more affordable vaccines, such as purified chicken embryo cell vaccines (CCEEV) and purified Vero cell rabies vaccines, have been developed and recommended by the World Health Organization (WHO). These modern vaccines are safer and more effective than their predecessors, contributing to the ongoing battle against rabies.
The development of the rabies vaccine is a testament to the power of scientific research and collaboration. By successfully testing the vaccine on animals and then treating Joseph Meister, Pasteur, Roux, and Grancher paved the way for future advancements and saved countless lives. Their work underscores the importance of preventive measures and the potential for innovative therapies to overcome challenging diseases.
TB Vaccine: Available in the US?
You may want to see also
Explore related products
The vaccine has been improved since 1885
The first rabies vaccine was introduced in 1885, and it has been improved significantly since then. In the late 19th century, rabies was a fatal disease with no cure. However, Louis Pasteur and his collaborator Émile Roux successfully treated nine-year-old Joseph Meister, who had been bitten multiple times by a rabid dog, with their new vaccine. Over the course of ten days, Dr. Jacques Joseph Grancher administered 12 doses of the vaccine, and Joseph Meister survived.
The original vaccine involved inoculation with homogenates of RABV-infected rabbit spinal cord that had been desiccated progressively in sterile air. The first injection was fully inactivated, and subsequent injections contained progressively more virulent preparations of the virus. This method proved highly effective, but it had some problems with consistency, which could lead to recipients developing rabies from the vaccination. This vaccine laid the foundation for future improvements and advancements in rabies prevention.
In 1908, an improved version of the rabies vaccine was introduced, and the development of cell culture for virus propagation ushered in a new era of rabies vaccine development. The first tissue culture vaccine was derived from a virus grown in primary hamster kidney cells. Subsequently, the use of a human diploid cell line, initially the lung-derived WI-38 cell line, and then the MRC-5 cell line, resulted in the licensing of a human diploid cell vaccine (HDCV) in the mid-1970s. This type of vaccine is inactivated and made using the attenuated Pitman-Moore L503 strain of the virus.
Today, newer and less expensive purified chicken embryo cell vaccines (CCEEV) and purified Vero cell rabies vaccines are available and recommended for use by the World Health Organization (WHO). These modern vaccines are safe for both humans and animals and can be used in pre- and post-exposure vaccinations. The WHO also recommends vaccinating individuals at high risk of contracting rabies, such as children living in endemic areas, veterinarians, and researchers.
Despite these advancements, rabies remains a significant public health concern worldwide, with thousands of human deaths occurring annually. The virus is almost always fatal once clinical symptoms manifest, and dog-mediated rabies accounts for the vast majority of human cases. As such, the vaccination of domestic animals remains crucial in preventing transmission to humans.
Memory Cells: Dynamic Storage, Ever-Changing
You may want to see also
Frequently asked questions
The first rabies vaccination for humans was invented in 1885 by French scientist Louis Pasteur.
Nine-year-old Joseph Meister was the first person to receive the rabies vaccine. In July 1885, he was bitten 14 times by a rabid dog and was successfully treated with the vaccine.
Three doses of the vaccine are given over a one-month period on days 0, 7, and either 21 or 28. For individuals potentially exposed to the virus, four doses are recommended over two weeks, along with an injection of rabies immunoglobulin.
